Evogene Ltd..
EVGN.US | Research and experimental development on natural sciences and engineering
Evogene Ltd. is an Israel-based computational biology company specializing in the discovery and development of novel products for life science markets. The company utilizes its proprietary computational biology platform, GeneRator AI, to predict and develop innovative solutions in agriculture, with ...Show More
Better Health for All
20
Evogene's subsidiary, Biomica, reported positive clinical signals in 72% of patients, stable disease in 64%, and sustained clinical benefit in 55% of patients during a Phase 1 clinical trial for its microbiome-based therapeutic, BMC128, for refractory cancers.
1
Canonic, another subsidiary, is developing medical cannabis products for specific medical indications like pain and inflammation, with pre-clinical studies showing anti-inflammatory and pain relief properties.
2
The safety profile for BMC128 is exceptional, with no major safety events reported during monotherapy or combination treatment in its Phase 1 clinical trial.
3
Canonic has filed a patent application for specific medical cannabis varieties and their medical effects, and a licensing agreement for two next-generation cannabis lines in Europe by GroVida indicates a willingness to license intellectual property.
4
Fair Money & Economic Opportunity
0
No evidence available to assess Evogene Ltd. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess Evogene Ltd. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, quantitative data for EVGN.US (Evogene Ltd.) regarding fair trade and ethical sourcing metrics was found in the provided articles. Several articles focused on other companies' practices or general ethical codes without providing measurable data for Evogene Ltd.'s supply chain performance.
1
Therefore, all KPIs for this value have been omitted due to lack of evidence.
Honest & Fair Business
-40
The company has a formal whistleblower policy that allows for anonymous reporting to the Compliance Officer or CFO, ensures confidentiality, and prohibits retaliation, outlining procedures for handling complaints regarding accounting, internal controls, or auditing matters.
1
However, there is no evidence of independent investigation processes. Additionally, the company has a zero-tolerance anti-corruption policy that adheres to the FCPA and other anti-bribery laws, requires prior written approval for gifts to government officials, and mandates annual training.
2
Despite this, there is no evidence regarding the effectiveness of this training or customization for high-risk areas.
Kind to Animals
-10
Evogene is identified as a major player in the Computational Toxicology Solutions market, which relies upon alternatives to animal testing.
1
This indicates that alternative methods are in routine use for internal safety screens. As a computational biology company, its core business model does not involve animal testing, making a specific animal testing policy and animal testing volume N/A.
2
Evogene is a member of the BIOTOV consortium, which includes companies and academic institutes active in agro-biotechnology, seed, and flavors, indicating participation in an industry consortium working on animal-free methods.
3
No War, No Weapons
0
No evidence available to assess Evogene Ltd. on No War, No Weapons.
Planet-Friendly Business
-70
Evogene Ltd. has conducted one Life Cycle Assessment (LCA) for its biodiesel produced from castor bean varieties, which was peer-reviewed.
1
Given the company's diverse product portfolio, this represents a small portion of its product lines. The company has received a €1.2 million EU Horizon grant for its Crop4Clima project, which aims to develop oil-seed crops with 60% higher carbon dioxide assimilation and 20% less water intake compared to standard crops.
2
The company's code of ethics states a commitment to observing environmental laws and regulations, and to prevent conduct inconsistent with them.
3
The company also mentions that castor beans can be grown on semi-arid lands, providing the benefit of not competing with food use of arable land.
4
Respect for Cultures & Communities
0
No specific quantitative data or concrete facts were provided across the articles to assess Evogene Ltd.'s performance against any of the KPIs for Respect for Cultures & Communities.
1
The available information primarily focuses on corporate governance, employee well-being, and general ESG reporting without specific metrics related to community engagement, cultural impact, or local stakeholder involvement.
Safe & Smart Tech
0
Evogene's privacy policy states that personal information will not be disclosed or shared with third parties, except in specific cases,
1
and its code of ethics prohibits employees from using non-public information for personal gain,
2
indicating no documented incidents of unauthorized data use. Users can delete or correct their personal information by email
3
and opt out of promotional emails,
4
which aligns with industry-standard user privacy controls. The company's privacy policy states that data is retained for a reasonable period to achieve collection purposes and comply with laws,
5
which is a standard approach to data minimization. Evogene also states it will disclose information to satisfy applicable laws, regulations, legal processes, or governmental requests,
6
and mentions compliance with applicable laws,
7
indicating basic regulatory compliance.
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles regarding Evogene Ltd.'s performance on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1
Mentions of "Plastic degradation" and "Waste-water treatments" were identified as potential markets for the company's AI technology, not as direct actions or outcomes related to the company's own waste management or product sustainability efforts.
2